These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7256184)

  • 41. High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease.
    Devenyi P; Robinson GM; Kapur BM; Roncari DA
    Am J Med; 1981 Oct; 71(4):589-94. PubMed ID: 7282747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of diphenylhydantoin on the relationship between high-density lipoprotein cholesterol and several biochemical assays.
    Allen JK; Whitfield JB; Hensley WJ
    Clin Chim Acta; 1980 Mar; 102(1):111-4. PubMed ID: 6104546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-density lipoprotein cholesterol and liver disease.
    Kanel GC; Radvan G; Peters RL
    Hepatology; 1983; 3(3):343-8. PubMed ID: 6840679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increase of serum high-density lipoprotein in phenytoin users.
    Nikkilä EA; Kaste M; Ehnholm C; Viikari J
    Br Med J; 1978 Jul; 2(6130):99. PubMed ID: 208710
    [No Abstract]   [Full Text] [Related]  

  • 45. Absence of inhibition of hepatic lipase by HDL.
    Demacker PN; Stuyt PM; Hijmans AG; Van 't Laar A
    Atherosclerosis; 1983 Jul; 48(1):101-3. PubMed ID: 6882505
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.
    Luoma PV; Reunanen MI; Sotaniemi EA
    Acta Med Scand; 1979; 206(3):229-31. PubMed ID: 495231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between serum high density lipoprotein content and liver function during experimental hepatic degeneration and regeneration.
    von Lehmann B; Grajewski O; Arntz HR; Oberdisse E
    Acta Hepatogastroenterol (Stuttg); 1976; 23(5):328-33. PubMed ID: 185875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epilepsy in the elderly].
    Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(11):66-7. PubMed ID: 16329641
    [No Abstract]   [Full Text] [Related]  

  • 49. [Manganese serum levels of epileptics].
    Hoffmann H
    Klin Wochenschr; 1980 Feb; 58(3):157-8. PubMed ID: 7366130
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cholesterol content of cadaveric blood in neoplastic malignancy; its relation to liver function and the effects of radiotherapy].
    HARTL F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1951 Aug; 213(3-4):235-48. PubMed ID: 14885984
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood cholesterol in epilepsy].
    PEREVOSHCHIKOVA GF
    Vopr Psikhiatr Nevropatol; 1962; 8():248-54. PubMed ID: 13942373
    [No Abstract]   [Full Text] [Related]  

  • 52. PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome.
    Hukkanen J; Hakkola J
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4
    Salonurmi T; Nabil H; Ronkainen J; Hyötyläinen T; Hautajärvi H; Savolainen MJ; Tolonen A; Orešič M; Känsäkoski P; Rysä J; Hakkola J; Hukkanen J
    Front Pharmacol; 2020; 11():361. PubMed ID: 32292343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity : A double-blind controlled trial of selenium supplementation.
    Luoma PV; Korpela H; Sotaniemi EA; Kumpulainen J
    Biol Trace Elem Res; 1985 Sep; 8(2):113-21. PubMed ID: 24257871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. QTL/microarray approach using pathway information.
    Matsuda H; Taniguchi Y; Iwaisaki H
    Algorithms Mol Biol; 2012 Jan; 7():1. PubMed ID: 22244197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.
    Luoma PV
    Eur J Clin Pharmacol; 2008 Sep; 64(9):841-50. PubMed ID: 18633604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.
    McAuley JW; Anderson GD
    Clin Pharmacokinet; 2002; 41(8):559-79. PubMed ID: 12102641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes.
    Luoma PV; Sotaniemi EA; Pelkonen RO; Pirttiaho HI
    Eur J Clin Pharmacol; 1985; 28(6):615-8. PubMed ID: 4065184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
    Luoma PV; Heikkinen JE; Ehnholm C; Ylöstalo PR
    Eur J Clin Pharmacol; 1987; 31(5):563-7. PubMed ID: 3104057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment.
    Luoma PV; Sotaniemi EA; Pelkonen RO; Myllylä VV
    Scand J Clin Lab Invest; 1980 Apr; 40(2):163-7. PubMed ID: 7256184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.